These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1183664)

  • 21. Immunoglobulin profile in HIV-1 infected children in Dar es Salaam.
    Lyamuya EF; Matee MI; Kasubi M; Scheutz F
    East Afr Med J; 1999 Jul; 76(7):370-5. PubMed ID: 10520363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the occurrence of anti-liver serum antibodies in porphyria cutanea tarda of the adult].
    Bădånoiu AL; Mateescu D; Gheorghiu GH
    Arch Klin Exp Dermatol; 1967; 229(2):139-48. PubMed ID: 4871412
    [No Abstract]   [Full Text] [Related]  

  • 23. [Concentration of serum transferrin in patients with porphyria cutanea tarda].
    Kansky A
    Hautarzt; 1970 Apr; 21(4):165-6. PubMed ID: 5524562
    [No Abstract]   [Full Text] [Related]  

  • 24. [The immunological reactivity indices (the humoral component) in persons in contact with mycotoxin-contaminated food products].
    Dadiani KR; Voĭto NE; Tutel'ian VA
    Vopr Pitan; 1990; (3):31-5. PubMed ID: 2399678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyria cutanea tarda associated with autoimmune hypothyroidism, vitiligo and alopecia universalis.
    Sabán J; Rodríguez-García JL; Gil J; País JR; Medina S
    Neth J Med; 1991 Dec; 39(5-6):350-2. PubMed ID: 1803247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantification of immunoglobulins, IgG, IgA, IgM, IgD and IgE, in biological fluids by enzymoimmunoanalysis].
    León VJ; León E; Ledesma M; López-Borrasca A
    Sangre (Barc); 1985; 30(5):864-70. PubMed ID: 3911459
    [No Abstract]   [Full Text] [Related]  

  • 29. [The application and value of immunofluorescence procedures in dermatology (author's transl)].
    Holubar K
    Wien Klin Wochenschr; 1974 Jun; 86(12):325-30. PubMed ID: 4599929
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sclerodermoid porphyria cutanea tarda associated with cataract].
    Bopp C; Peres M; Kosminski B; Azambuja M; Bakos L
    Med Cutan Ibero Lat Am; 1975; 3(2):149-59. PubMed ID: 1240568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
    Grossman ME; Poh-Fitzpatrick MB
    Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of immunoglobulins in acute and chronic coronary disease].
    Zimmermann S; Lewicki I; Lewicki D
    Z Gesamte Inn Med; 1975 Dec; 30(23):257 concl. PubMed ID: 1224734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of humoral immunology in delayed hepatocutaneous porphyrias alcoholic variety].
    Betancor León P; García de Lomas J; del rey Calero J; Schüller Pérez A
    Rev Esp Enferm Apar Dig; 1977 Dec; 51(7):751-62. PubMed ID: 594477
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of Carbolen in the treatment of porphyria cutanea tarda. In relation to the article by B.S. Pankov: "Carbolen in the treatment of porphyria cutanea tarda" (Vestnik dermatologii i venerologii, No 4, 1967)].
    Krivosheev BN
    Vestn Dermatol Venerol; 1969 May; 43(5):63-6. PubMed ID: 5368061
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic changes during specific treatment of the atopic state. IV. Blocking activity of isolated IgG, IgA, and IgM with a specific allergen-binding capacity.
    Zavázal V; Stajner A; Sindelár J
    Acta Allergol; 1972 Apr; 27(2):119-29. PubMed ID: 4559771
    [No Abstract]   [Full Text] [Related]  

  • 37. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progresses in the field of immunodermatology].
    Jabłoónska S; Chorzelski T
    Z Hautkr; 1974 Sep; 49(17):721-9. PubMed ID: 4373951
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological and biochemical findings in patients with porphyria cutanea tarda.
    Błaszczyk M; Daoud S; Chorzelski T; Jabłońska S; Sulej J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):757-62. PubMed ID: 7349094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.